Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

754
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
754
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

937
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
937
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.6K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.6K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

2.4K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.4K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.6K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.6K
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

821
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
821

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Novel, Robust, and Isocratic HPLC-UV Method for the Comprehensive Determination of Enantiomeric Impurity (R-Isomer) in Niraparib Drug Substance.

Chirality·2026
Same author

The assetization of care? A comparative exploration of investor logic in healthcare systems in England, Canada, and the Netherlands.

Health economics, policy, and law·2026
Same author

Designing and delivering youth mental health services for young people, with young people: what works? A protocol for a realist eDelphi study on effective co-production.

BMJ open·2026
Same author

Referral pathways into the NHS Digital Weight Management Programme for musculoskeletal and perioperative patients: rapid process evaluation.

Health and social care delivery research·2026
Same author

Genomic characterization and SNP analysis connect respiratory infections caused by <i>Mycobacterium intracellulare</i> with a pool facility.

Microbial genomics·2025
Same author

Review of residential and nursing care home policies on safety incident reporting in England.

Journal of health services research & policy·2025
Same journal

National Notifiable Diseases Surveillance System, 1 October to 31 December 2017.

Communicable diseases intelligence quarterly report·2018
Same journal

National Notifiable Diseases Surveillance System, 1 July to 30 September 2017.

Communicable diseases intelligence quarterly report·2018
Same journal

National Notifiable Diseases Surveillance System, 1 April to 30 June 2017.

Communicable diseases intelligence quarterly report·2018
Same journal

OzFoodNet quarterly report, 1 July to 30 September 2015.

Communicable diseases intelligence quarterly report·2018
Same journal

OzFoodNet quarterly report, 1 April to 30 June 2015.

Communicable diseases intelligence quarterly report·2018
Same journal

The Australian Sentinel Practices Research Network, 1 January to 31 March 2017.

Communicable diseases intelligence quarterly report·2018
See all related articles

Related Experiment Video

Updated: Apr 18, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.4K

Tuberculosis notifications in Australia, 2011.

Christina Bareja1, Justin Waring2, Richard Stapledon3

  • 1Vaccine Preventable Diseases Surveillance Section, Health Emergency Management Branch, Office of Health Protection, Department of Health, Canberra, Australian Capital Territory.

Communicable Diseases Intelligence Quarterly Report
|January 30, 2015
PubMed
Summary
This summary is machine-generated.

Australia

More Related Videos

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

15.0K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.8K

Related Experiment Videos

Last Updated: Apr 18, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.4K
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

15.0K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.8K

Area of Science:

  • Public Health
  • Infectious Disease Epidemiology

Background:

  • Tuberculosis (TB) rates in Australia have remained stable at 5-6 cases per 100,000 population since the mid-1980s.
  • Despite overall stability, a gradual increase in TB incidence has been observed over the last decade.
  • The overseas-born population significantly contributes to TB notifications.

Purpose of the Study:

  • To analyze tuberculosis (TB) notification trends in Australia for 2011.
  • To identify demographic groups with varying TB incidence rates.
  • To assess the burden of multi-drug-resistant TB (MDR-TB) in Australia.

Main Methods:

  • Analysis of tuberculosis (TB) notification data from the National Notifiable Diseases Surveillance System for 2011.
  • Calculation of TB incidence rates per 100,000 population for different demographic groups.
  • Examination of trends in TB and multi-drug-resistant TB (MDR-TB) cases.

Main Results:

  • In 2011, Australia recorded 1,385 TB notifications at a rate of 6.2 per 100,000 population.
  • Overseas-born individuals accounted for 88% of notifications with a rate of 20.2 per 100,000.
  • The Australian-born Indigenous population showed a decrease in TB notification rate to 4.9 per 100,000 in 2011, while the non-Indigenous rate remained low at 0.9 per 100,000.
  • Twenty-five multi-drug-resistant TB (MDR-TB) cases were reported, exclusively in the overseas-born population.

Conclusions:

  • Maintaining robust national TB surveillance is crucial for monitoring trends and targeting at-risk populations.
  • Continued contribution to global TB control initiatives is essential for Australia to sustain low TB rates and work towards further reductions.
  • Addressing TB in overseas-born populations remains a key focus for national control efforts.